Saba Capital Management, L.P. bought HQL
June 10, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 9,704 shares of Abrdn Life Sciences Investors at $13.71 per share, a transaction worth $133.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
9,704
Price
$13.71
Total value
$133.0K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 10, 2024
Filing dateJune 11, 2024
Shares owned after3,403,173
OwnershipIndirect
10b5-1 planNo
AmendedNo